Finance

Lists
Why is 4015 up 3,02%?
Dive Deeper
4015:TADAWUL
Jamjoom Pharmaceuticals Fctry Cmpny SJSC
126,30 SAR
+3,02%
(+3,70) 1D
15-окт., 15:13:04 GMT+3  ·   SAR
All symbols
SymbolPriceChange% Change
Generating top insights for 4015...
Open
122,00 SAR
High
126,30 SAR
Low
122,00 SAR
Mkt. cap
8,84 млд
Avg. vol.
32,60 миң
Volume
68,86 миң
Dividend
3,33%
Quarterly dividend
1,05 SAR
Ex-dividend date
2026-ж., 2-авг.
P/E ratio
18,40
52-wk high
165,30 SAR
52-wk low
121,80 SAR
EPS
6,87 SAR
Shares outstanding
29,31 млн
No. of employees
1 миң
Open
122,00 SAR
High
126,30 SAR
Low
122,00 SAR
Mkt. cap
8,84 млд
Avg. vol.
32,60 миң
Volume
68,86 миң
Dividend
3,33%
Quarterly dividend
1,05 SAR
Ex-dividend date
2026-ж., 2-авг.
P/E ratio
18,40
52-wk high
165,30 SAR
52-wk low
121,80 SAR
EPS
6,87 SAR
Shares outstanding
29,31 млн
No. of employees
1 миң
News stories
From web sources and news partners
About Jamjoom Pharmaceuticals Fctry Cmpny SJSC
CEO-
Employees1,13 миң
Founded1994
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in SAR
Loading Previous Earnings...
Revenue
Net income
All values in SAR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
342,31 млн
304,57 млн
481,38 млн
445,31 млн
Cost of goods sold
133,77 млн
121,19 млн
171,00 млн
151,66 млн
Cost of revenue
133,77 млн
121,19 млн
171,00 млн
151,66 млн
Research and development expenses
9,47 млн
10,86 млн
9,40 млн
10,94 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
90,86 млн
110,53 млн
125,39 млн
139,66 млн
Operating expense
98,61 млн
111,72 млн
138,01 млн
147,65 млн
Total operating expenses
232,38 млн
232,91 млн
309,01 млн
299,32 млн
Operating income
109,92 млн
71,66 млн
172,38 млн
146,00 млн
Other non operating income
-
-1,17 млн
-
-
EBT including unusual items
113,34 млн
76,91 млн
174,94 млн
146,22 млн
EBT excluding unusual items
113,34 млн
77,01 млн
174,94 млн
146,22 млн
Income tax expense
6,67 млн
8,84 млн
6,73 млн
8,59 млн
Effective tax rate
5,89%
11,49%
3,85%
5,87%
Other operating expenses
-1,72 млн
-8,56 млн
3,22 млн
-2,95 млн
Net income
106,67 млн
68,07 млн
168,21 млн
137,63 млн
Net profit margin
31,16%
22,35%
34,94%
30,91%
Earnings per share
-
-
-
-
Interest and investment income
991,15 миң
784,73 миң
2,32 млн
1,36 млн
Interest expense
-353,59 миң
-
-1,54 млн
-954,23 миң
Net interest expenses
637,55 миң
784,73 миң
785,30 миң
408,85 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
120,95 млн
82,25 млн
183,73 млн
157,44 млн
Gain or loss from assets sale
18,06 миң
8,39 миң
34,74 миң
1,30 миң
AI content may include mistakes. Learn more
Google колдонмолору